Category: biotech

.Biogen has provided the final ceremonies to its own collaboration with Sage Therapies on SAGE-324, ditching the partnership in the results of a failed research

.Biogen as well as UCB’s rely on improving in to stage 3 astride an unsuccessful study seeks to have actually paid off, with the partners

.Accept to today’s Chutes &amp Ladders, our summary of substantial management hirings, firings as well as retirings across the business. Please send the good word–

.After BioMarin performed a spring well-maintained of its own pipe in April, the firm has determined that it additionally requires to offload a preclinical gene

.BioMarin is actually including combustion to the R&ampD fire, assaulting a match with CAMP4 Therapeutics for rights to select pair of aim ats recognized by

.Invite to this week’s Chutes &amp Ladders, our summary of notable management hirings, shootings and retirings throughout the sector. Feel free to send out the

.BioAge Labs is introducing virtually $200 thousand via its Nasdaq IPO this morning, with the profits earmarked for taking its lead obesity medication further right

.BioAge Labs is considering around $180 thousand in initial proceeds coming from an IPO and a private positioning, funds the metabolic-focused biotech are going to

.Major Pharma is spending greatly in AI to reduce progression timetables and foster advancement. However instead of reinforcing future relationships with the biotech world, the

.Bayer managers were interested to anxiety to Intense this summer months that the German pharma titan’s hunger for dealmaking have not been actually inhibited through